Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

PIII vs UNH vs CVS vs ALHC vs OSCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PIII
P3 Health Partners Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10M
5Y Perf.-99.3%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$344.90B
5Y Perf.-4.7%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$115.54B
5Y Perf.+18.5%
ALHC
Alignment Healthcare, Inc.

Medical - Healthcare Plans

HealthcareNASDAQ • US
Market Cap$3.66B
5Y Perf.-32.4%
OSCR
Oscar Health, Inc.

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$5.53B
5Y Perf.-6.2%

PIII vs UNH vs CVS vs ALHC vs OSCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PIII logoPIII
UNH logoUNH
CVS logoCVS
ALHC logoALHC
OSCR logoOSCR
IndustryMedical - Care FacilitiesMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare Plans
Market Cap$10M$344.90B$115.54B$3.66B$5.53B
Revenue (TTM)$1.44B$449.71B$407.90B$4.26B$13.30B
Net Income (TTM)$-131M$12.04B$2.93B$20M$-39M
Gross Margin48.2%18.8%13.9%9.0%17.4%
Operating Margin-17.6%4.2%1.5%0.8%0.1%
Forward P/E20.7x12.4x101.8x26.7x
Total Debt$166M$78.39B$93.59B$338M$430M
Cash & Equiv.$39M$24.36B$8.51B$578M$2.77B

PIII vs UNH vs CVS vs ALHC vs OSCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PIII
UNH
CVS
ALHC
OSCR
StockApr 21May 26Return
P3 Health Partners … (PIII)1000.7-99.3%
UnitedHealth Group … (UNH)10095.3-4.7%
CVS Health Corporat… (CVS)100118.5+18.5%
Alignment Healthcar… (ALHC)10067.6-32.4%
Oscar Health, Inc. (OSCR)10093.8-6.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: PIII vs UNH vs CVS vs ALHC vs OSCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. CVS Health Corporation is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. PIII and ALHC also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
PIII
P3 Health Partners Inc.
The Defensive Pick

PIII ranks third and is worth considering specifically for sleep-well-at-night.

  • Lower volatility, beta 0.09, current ratio 0.37x
  • Beta 0.09 vs OSCR's 1.83
Best for: sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 228.3% 10Y total return vs CVS's 6.6%
  • 2.7% margin vs PIII's -9.1%
  • 2.3% yield, 25-year raise streak, vs CVS's 3.0%, (3 stocks pay no dividend)
  • 3.9% ROA vs PIII's -19.2%, ROIC 9.2% vs -60.2%
Best for: long-term compounding
CVS
CVS Health Corporation
The Insurance Pick

CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.

  • Dividend streak 0 yrs, beta 0.13, yield 3.0%
  • Beta 0.13, yield 3.0%, current ratio 0.84x
  • Lower P/E (12.4x vs 101.8x)
  • +37.4% vs PIII's -58.5%
Best for: income & stability and defensive
ALHC
Alignment Healthcare, Inc.
The Insurance Pick

ALHC is the clearest fit if your priority is growth exposure.

  • Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
  • 46.1% revenue growth vs CVS's 7.8%
Best for: growth exposure
OSCR
Oscar Health, Inc.
The Insurance Play

Among these 5 stocks, OSCR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthALHC logoALHC46.1% revenue growth vs CVS's 7.8%
ValueCVS logoCVSLower P/E (12.4x vs 101.8x)
Quality / MarginsUNH logoUNH2.7% margin vs PIII's -9.1%
Stability / SafetyPIII logoPIIIBeta 0.09 vs OSCR's 1.83
DividendsUNH logoUNH2.3% yield, 25-year raise streak, vs CVS's 3.0%, (3 stocks pay no dividend)
Momentum (1Y)CVS logoCVS+37.4% vs PIII's -58.5%
Efficiency (ROA)UNH logoUNH3.9% ROA vs PIII's -19.2%, ROIC 9.2% vs -60.2%

PIII vs UNH vs CVS vs ALHC vs OSCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PIIIP3 Health Partners Inc.
FY 2024
Capitated Revenue
98.9%$1.5B
Health Care, Patient Service
1.1%$17M
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
ALHCAlignment Healthcare, Inc.
FY 2023
Health Care, Premium
92.6%$1.7B
Health Care Capitation
7.4%$133M
OSCROscar Health, Inc.

Segment breakdown not available.

PIII vs UNH vs CVS vs ALHC vs OSCR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGALHC

Income & Cash Flow (Last 12 Months)

Evenly matched — UNH and OSCR each lead in 2 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 311.2x PIII's $1.4B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to PIII's -9.1%. On growth, OSCR holds the edge at +52.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
RevenueTrailing 12 months$1.4B$449.7B$407.9B$4.3B$13.3B
EBITDAEarnings before interest/tax-$171M$23.2B$10.5B$66M$40M
Net IncomeAfter-tax profit-$131M$12.0B$2.9B$20M-$39M
Free Cash FlowCash after capex-$123M$19.7B$7.4B$237M$2.8B
Gross MarginGross profit ÷ Revenue+48.2%+18.8%+13.9%+9.0%+17.4%
Operating MarginEBIT ÷ Revenue-17.6%+4.2%+1.5%+0.8%+0.1%
Net MarginNet income ÷ Revenue-9.1%+2.7%+0.7%+0.5%-0.3%
FCF MarginFCF ÷ Revenue-8.5%+4.4%+1.8%+5.6%+21.0%
Rev. Growth (YoY)Latest quarter vs prior year-4.7%+2.0%+6.2%+33.3%+52.6%
EPS Growth (YoY)Latest quarter vs prior year+38.4%+0.7%+63.1%+2.1%+125.0%
Evenly matched — UNH and OSCR each lead in 2 of 6 comparable metrics.

Valuation Metrics

Evenly matched — PIII and CVS each lead in 2 of 6 comparable metrics.

At 28.7x trailing earnings, UNH trades at a 56% valuation discount to CVS's 65.1x P/E. On an enterprise value basis, CVS's 13.4x EV/EBITDA is more attractive than ALHC's 75.7x.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
Market CapShares × price$10M$344.9B$115.5B$3.7B$5.5B
Enterprise ValueMkt cap + debt − cash$138M$398.9B$200.6B$3.4B$3.2B
Trailing P/EPrice ÷ TTM EPS-0.07x28.72x65.14x-4845.95x-12.61x
Forward P/EPrice ÷ next-FY EPS est.20.71x12.39x101.82x26.68x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.10x13.38x75.68x
Price / SalesMarket cap ÷ Revenue0.01x0.77x0.29x0.93x0.47x
Price / BookPrice ÷ Book value/share0.07x3.40x1.53x19.80x5.70x
Price / FCFMarket cap ÷ FCF21.46x14.80x32.37x5.22x
Evenly matched — PIII and CVS each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 9 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for PIII. OSCR carries lower financial leverage with a 0.44x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs PIII's 2/9, reflecting solid financial health.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
ROE (TTM)Return on equity-6.9%+11.5%+3.9%+11.5%-3.3%
ROA (TTM)Return on assets-19.2%+3.9%+1.1%+1.8%-0.6%
ROICReturn on invested capital-60.2%+9.2%+5.0%
ROCEReturn on capital employed-75.6%+9.7%+6.1%+2.9%-25.3%
Piotroski ScoreFundamental quality 0–926564
Debt / EquityFinancial leverage1.11x0.77x1.24x1.89x0.44x
Net DebtTotal debt minus cash$127M$54.0B$85.1B-$240M-$2.3B
Cash & Equiv.Liquid assets$39M$24.4B$8.5B$578M$2.8B
Total DebtShort + long-term debt$166M$78.4B$93.6B$338M$430M
Interest CoverageEBIT ÷ Interest expense-5.02x4.71x2.11x1.27x-0.57x
UNH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

OSCR leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in CVS five years ago would be worth $11,977 today (with dividends reinvested), compared to $73 for PIII. Over the past 12 months, CVS leads with a +37.4% total return vs PIII's -58.5%. The 3-year compound annual growth rate (CAGR) favors OSCR at 41.5% vs PIII's -66.7% — a key indicator of consistent wealth creation.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
YTD ReturnYear-to-date+1.4%+13.6%+14.7%-11.3%+42.4%
1-Year ReturnPast 12 months-58.5%+0.8%+37.4%+16.3%+24.9%
3-Year ReturnCumulative with dividends-96.3%-17.8%+41.2%+148.0%+183.4%
5-Year ReturnCumulative with dividends-99.3%-0.9%+19.8%-16.6%-5.7%
10-Year ReturnCumulative with dividends-99.3%+228.3%+6.6%+3.6%-38.8%
CAGR (3Y)Annualised 3-year return-66.7%-6.3%+12.2%+35.4%+41.5%
OSCR leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — PIII and CVS each lead in 1 of 2 comparable metrics.

PIII is the less volatile stock with a 0.09 beta — it tends to amplify market swings less than OSCR's 1.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 99.6% from its 52-week high vs PIII's 31.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
Beta (5Y)Sensitivity to S&P 5000.09x0.60x0.13x0.81x1.83x
52-Week HighHighest price in past year$11.30$390.92$90.88$23.87$23.80
52-Week LowLowest price in past year$1.52$234.60$58.35$11.63$10.69
% of 52W HighCurrent price vs 52-week peak+31.4%+97.2%+99.6%+75.1%+89.5%
RSI (14)Momentum oscillator 0–10069.576.970.038.181.6
Avg Volume (50D)Average daily shares traded62K7.9M7.5M3.6M6.5M
Evenly matched — PIII and CVS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst consensus: PIII as "Buy", UNH as "Buy", CVS as "Buy", ALHC as "Buy", OSCR as "Hold". Consensus price targets imply 252.3% upside for PIII (target: $13) vs -12.0% for OSCR (target: $19). For income investors, CVS offers the higher dividend yield at 2.95% vs UNH's 2.29%.

MetricPIII logoPIIIP3 Health Partner…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…ALHC logoALHCAlignment Healthc…OSCR logoOSCROscar Health, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyHold
Price TargetConsensus 12-month target$12.50$385.43$96.75$24.83$18.75
# AnalystsCovering analysts452411611
Dividend YieldAnnual dividend ÷ price+2.3%+3.0%
Dividend StreakConsecutive years of raises250
Dividend / ShareAnnual DPS$8.70$2.67
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.6%0.0%0.0%0.0%
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway

UNH leads in 1 of 6 categories (Profitability & Efficiency). OSCR leads in 1 (Total Returns). 4 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 1 of 6 categories
Loading custom metrics...

PIII vs UNH vs CVS vs ALHC vs OSCR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PIII or UNH or CVS or ALHC or OSCR a better buy right now?

For growth investors, Alignment Healthcare, Inc.

(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). UnitedHealth Group Incorporated (UNH) offers the better valuation at 28. 7x trailing P/E (20. 7x forward), making it the more compelling value choice. Analysts rate P3 Health Partners Inc. (PIII) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PIII or UNH or CVS or ALHC or OSCR?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 28.

7x versus CVS Health Corporation at 65. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — PIII or UNH or CVS or ALHC or OSCR?

Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +19.

8%, compared to -99. 3% for P3 Health Partners Inc. (PIII). Over 10 years, the gap is even starker: UNH returned +228. 3% versus PIII's -99. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PIII or UNH or CVS or ALHC or OSCR?

By beta (market sensitivity over 5 years), P3 Health Partners Inc.

(PIII) is the lower-risk stock at 0. 09β versus Oscar Health, Inc. 's 1. 83β — meaning OSCR is approximately 1927% more volatile than PIII relative to the S&P 500. On balance sheet safety, Oscar Health, Inc. (OSCR) carries a lower debt/equity ratio of 44% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — PIII or UNH or CVS or ALHC or OSCR?

By revenue growth (latest reported year), Alignment Healthcare, Inc.

(ALHC) is pulling ahead at 46. 1% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -1865. 9% for Oscar Health, Inc.. Over a 3-year CAGR, OSCR leads at 41. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PIII or UNH or CVS or ALHC or OSCR?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -9. 1% for P3 Health Partners Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -21. 4% for PIII. At the gross margin level — before operating expenses — PIII leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PIII or UNH or CVS or ALHC or OSCR more undervalued right now?

On forward earnings alone, CVS Health Corporation (CVS) trades at 12.

4x forward P/E versus 101. 8x for Alignment Healthcare, Inc. — 89. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PIII: 252. 3% to $12. 50.

08

Which pays a better dividend — PIII or UNH or CVS or ALHC or OSCR?

In this comparison, CVS (3.

0% yield), UNH (2. 3% yield) pay a dividend. PIII, ALHC, OSCR do not pay a meaningful dividend and should not be held primarily for income.

09

Is PIII or UNH or CVS or ALHC or OSCR better for a retirement portfolio?

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

13), 3. 0% yield). Oscar Health, Inc. (OSCR) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +6. 6%, OSCR: -38. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PIII and UNH and CVS and ALHC and OSCR?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: PIII is a small-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap quality compounder stock; ALHC is a small-cap high-growth stock; OSCR is a small-cap high-growth stock. UNH, CVS pay a dividend while PIII, ALHC, OSCR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PIII

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 28%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

ALHC

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 16%
Run This Screen
Stocks Like

OSCR

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 26%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PIII and UNH and CVS and ALHC and OSCR on the metrics below

Revenue Growth>
%
(PIII: -4.7% · UNH: 2.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.